These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919 [TBL] [Abstract][Full Text] [Related]
24. Use of teriparatide in osteoporotic fracture patients. Collinge C; Favela J Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289 [TBL] [Abstract][Full Text] [Related]
25. The Effect of Bisphosphonates on the Clinical and Radiographic Outcomes of Distal Radius Fractures in Women. Shoji KE; Earp BE; Rozental TD J Hand Surg Am; 2018 Feb; 43(2):115-122. PubMed ID: 29054355 [TBL] [Abstract][Full Text] [Related]
26. [Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture model--effects of osteoporosis treatment drugs on fracture healing process]. Mashiba T Clin Calcium; 2011 Apr; 21(4):551-8. PubMed ID: 21447922 [TBL] [Abstract][Full Text] [Related]
27. Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance. Ke CH; Li HY; Yang D; Ying H; Xu J; Wang J; Zhu HW; Wang L Orthop Surg; 2021 Dec; 13(8):2433-2441. PubMed ID: 34676672 [TBL] [Abstract][Full Text] [Related]
28. Association between timing of zoledronic acid infusion and hip fracture healing. Colón-Emeric C; Nordsletten L; Olson S; Major N; Boonen S; Haentjens P; Mesenbrink P; Magaziner J; Adachi J; Lyles KW; Hyldstrup L; Bucci-Rechtweg C; Recknor C; Osteoporos Int; 2011 Aug; 22(8):2329-36. PubMed ID: 21153021 [TBL] [Abstract][Full Text] [Related]
29. Bisphosphonates and atypical femoral fractures: Is the location of the fracture associated with the time of consolidation? Llano L; Barla J; Taype D; Garcia Barreiro G; Sancineto C; Carabelli G Injury; 2023 Nov; 54 Suppl 6():110730. PubMed ID: 38143116 [TBL] [Abstract][Full Text] [Related]
30. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures. Phillips HK; Harrison SJ; Akrawi H; Sidhom SA Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753 [TBL] [Abstract][Full Text] [Related]
32. Benefits and risks of bisphosphonate therapy for osteoporosis. Khosla S; Bilezikian JP; Dempster DW; Lewiecki EM; Miller PD; Neer RM; Recker RR; Shane E; Shoback D; Potts JT J Clin Endocrinol Metab; 2012 Jul; 97(7):2272-82. PubMed ID: 22523337 [TBL] [Abstract][Full Text] [Related]
33. Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: A multicenter retrospective study. Lee KJ; Yoo JJ; Oh KJ; Yoo JH; Rhyu KH; Nam KW; Suh DH Injury; 2017 Apr; 48(4):941-945. PubMed ID: 28274470 [TBL] [Abstract][Full Text] [Related]
34. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration. Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400 [TBL] [Abstract][Full Text] [Related]
35. Healing Time and Complications in Operatively Treated Atypical Femur Fractures Associated With Bisphosphonate Use: A Multicenter Retrospective Cohort. Bogdan Y; Tornetta P; Einhorn TA; Guy P; Leveille L; Robinson J; Bosse MJ; Haines N; Horwitz D; Jones C; Schemitsch E; Sagi C; Thomas B; Stahl D; Ricci W; Brady M; Sanders D; Kain M; Higgins TF; Collinge C; Kottmeier S; Friess D J Orthop Trauma; 2016 Apr; 30(4):177-81. PubMed ID: 26709814 [TBL] [Abstract][Full Text] [Related]
36. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509 [TBL] [Abstract][Full Text] [Related]
37. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Rizzoli R; Akesson K; Bouxsein M; Kanis JA; Napoli N; Papapoulos S; Reginster JY; Cooper C Osteoporos Int; 2011 Feb; 22(2):373-90. PubMed ID: 21085935 [TBL] [Abstract][Full Text] [Related]
38. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study. Iwata A; Kanayama M; Oha F; Hashimoto T; Iwasaki N BMC Musculoskelet Disord; 2017 Apr; 18(1):148. PubMed ID: 28388910 [TBL] [Abstract][Full Text] [Related]
39. Salvage of failed osteosynthesis for an atypical subtrochanteric femoral fracture associated with long-term bisphosphonate treatment using a 95° angled blade plate. Kim SM; Rhyu KH; Lim SJ Bone Joint J; 2018 Nov; 100-B(11):1511-1517. PubMed ID: 30418051 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates. Shin DY; Ku CR; Kim KM; Choi HS; Rhee Y; Lee EJ; Lim SK Korean J Intern Med; 2012 Mar; 27(1):98-102. PubMed ID: 22403507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]